Cresco Labs (CRLBF) Capital Expenditures (2020 - 2026)

Cresco Labs' Capital Expenditures history runs 7 years deep, the most recent figure standing at -$7.6 million for Q1 2026.

• Quarterly Capital Expenditures fell 31.28% year-over-year to -$7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.3 million (up 641.05% YoY) and the FY2025 annual result came in at $35.1 million, up 7071.02% from the prior year.
• Capital Expenditures was -$7.6 million for Q1 2026 at Cresco Labs, down from $61.3 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $152.9 million in Q4 2022 and bottomed at -$39.8 million in Q2 2023.
• A 5-year average of $9.8 million and a median of -$7.2 million in 2025 frame the typical range for Capital Expenditures.
• Peak annual rise in Capital Expenditures reached 265.12% in 2025, while the deepest fall reached 800.96% in 2025.
• Cresco Labs' Capital Expenditures stood at $152.9 million in 2022, then slumped by 30.71% to $106.0 million in 2023, then plunged by 84.16% to $16.8 million in 2024, then soared by 265.12% to $61.3 million in 2025, then tumbled by 112.47% to -$7.6 million in 2026.
• Business Quant data shows CRLBF's Capital Expenditures at -$7.6 million in Q1 2026, $61.3 million in Q4 2025, and -$7.2 million in Q3 2025.